US Political, Legislative and Regulatory Issues Analyses - Washington Analysis

Offering a wide spectrum of analyses on political, legislative and regulatory issues in US that impact equity and debt markets

Voted by money managers as No. 1 among independent research brokers in providing Washington coverage in the 2005 Institutional Investor annual survey

Founded in 1973, Washington Analysis Corporation (WAC) is the top-rated independent institutional research boutique focused on analyzing and anticipating changes in public policy in US that will impact the financial markets. Its expertise lies in assessing investment risks and opportunities emanating from developments on the political/geo-political front, as well as those stemming from economic, legislative and regulatory initiatives. WAC staff, which includes the firm's original partners, several of whom remain active with the firm, have built esteemed careers on both Capitol Hill and Wall Street. This stability among the research staff is complimented by a unique institutional expertise in its niche coverage area. A member of the Xinhua Finance family since July 2005, the firm is strategically-based in downtown Washington D.C., where it can remain best "plugged in" to the latest American policy changes.

Products offered by WAC include:

Washington This Week is a weekly publication that highlights important developments relevant to various industries impacted by Washington regulation and legislation.

Capital Comments is published every Monday. It discusses the legislative and regulatory activity scheduled for the coming week and includes the week's calendar of congressional hearings, regulatory meetings and economic data releases. The scheduled release of any government reports that might impact a specific regulated industry is included as well.

Political Pulse goes out weekly during an election year. It includes polls, political humor, comments, and analyses from a variety of sources that could help predict the election outcome.

Industry Updates are published ad hoc and cover specific industries/stocks affected by Washington regulation and legislation.

FDA Advisory Review is published every two months. It is a comprehensive report on FDA activity and includes tables of new chemical entity approvals, biological approvals, generic drug approvals, advisory committee recommendations, and a schedule of upcoming FDA advisory committee meetings.

Healthcare Calendar is published at the beginning of every month and lists the upcoming drug user fee dates, FDA advisory committee meetings, expected release of proposed or final rules from the FDA or the Centers for Medicare and Medicaid Services (CMS), and CMS Open Door Forums on healthcare providers.